LDHA and endometrial cancer: Investigation of LDHA inhibition in cancer cells revealed that LDHA inhibitor AZ-33 considerably hampered endometrial cancer cell proliferation in vitro and in vivo (Fig. 6F and Supplementary Fig. S10D, E), especially in cells with ALDH activity (Fig. 6G).